Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AUROBINDO PHARMA LTD

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 47
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

MARKSANS PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 73
  • 0 comments

FDA approve LORATADINE

Comment Full text

GENENTECH INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 64
  • 0 comments

FDA approve PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF

Comment Full text

RISING

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 62
  • 0 comments

FDA approve DOXERCALCIFEROL

Comment Full text

UMEDICA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 52
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text

SENORES PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 71
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

UNICHEM

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 68
  • 0 comments

FDA approve ETODOLAC

Comment Full text

STERISCIENCE

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 70
  • 0 comments

FDA approve SUMATRIPTAN SUCCINATE

Comment Full text

NEXUS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 73
  • 0 comments

FDA approve METHYLENE BLUE

Comment Full text

ALEMBIC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 66
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text
  • Previous
  • 287
  • 288
  • 289
  • 290
  • 291
  • Next

Search

News categories

  • Technical Exchange News(14633)
  • Event(6229)
  • SEC News(387520)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(236796)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin